Cargando…
Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis
We have previously shown that high expression of prolactin-induced protein (PIP) correlates with the response of breast cancer (BC) patients to standard adjuvant chemotherapy (doxorubicin and cyclophosphamide), which suggests that the absence of this glycoprotein is associated with resistance of tum...
Autores principales: | Urbaniak, Anna, Jablonska, Karolina, Suchanski, Jaroslaw, Partynska, Aleksandra, Szymczak-Kulus, Katarzyna, Matkowski, Rafal, Maciejczyk, Adam, Ugorski, Maciej, Dziegiel, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121699/ https://www.ncbi.nlm.nih.gov/pubmed/37085653 http://dx.doi.org/10.1038/s41598-023-33707-w |
Ejemplares similares
-
Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer
por: Sauer, Natalia, et al.
Publicado: (2023) -
Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression
por: Suchanski, Jaroslaw, et al.
Publicado: (2018) -
Galactosylceramide Affects Tumorigenic and Metastatic Properties of Breast Cancer Cells as an Anti-Apoptotic Molecule
por: Owczarek, Tomasz B., et al.
Publicado: (2013) -
Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression
por: Suchanski, Jaroslaw, et al.
Publicado: (2017) -
Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease
por: Reza, Safoura, et al.
Publicado: (2021)